Max Robotics — Global Service Robot Directory + US Certification

About

Felix Chun is a leading urologic oncologist whose research focuses on the comparative effectiveness and health economics of robot-assisted versus open surgery for major urological cancers. His work critically evaluates whether the technological promise of robotic surgery translates into tangible improvements in patient outcomes and healthcare costs. Chun’s major contributions include landmark analyses using large national databases, such as the National Inpatient Sample, to compare in-hospital outcomes for radical cystectomy, nephroureterectomy, and partial nephrectomy. His 2025 study on robot-assisted versus open radical cystectomy (12 citations) quantified adverse event reductions, while his work on nephroureterectomy (16 citations) and partial nephrectomy (5 citations) provided crucial real-world evidence. Notably, his research on total hospital costs (14 citations) and cost comparisons across five major cancers (8 citations) has informed surgical decision-making and healthcare policy. Chun also led a comprehensive systematic review and meta-analysis (10 citations) examining how different surgical approaches for radical prostatectomy impact urinary continence recovery. By systematically evaluating outcomes and costs, Felix Chun has become a key voice in evidence-based surgical oncology, helping surgeons and patients navigate the complex trade-offs between robotic and open techniques.